3
Graph AI, a California-based AI life sciences company specialising in patient safety and pharmacovigilance, has secured $3 million in a seed funding round led by Bessemer Venture Partners.
Founded in 2024, Graph AI aims to disrupt pharmacovigilance, a regulatory mandate requiring continuous monitoring and reporting of adverse drug events throughout a drug’s lifecycle.
Traditionally, pharmaceutical companies have relied on large service providers with manual and fragmented workflows, resulting in slow and error-prone processes.
Graph AI’s platform…
